Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study

…, J Hwa, J Koff, H Menninger, N Neparidze… - The Lancet …, 2020 - thelancet.com
Background An important feature of severe acute respiratory syndrome coronavirus 2
pathogenesis is COVID-19-associated coagulopathy, characterised by increased thrombotic and …

[HTML][HTML] Human keratinocytes express functional CD14 and toll-like receptor 4

PI Song, N Neparidze, CA Armstrong, JC Ansel… - Journal of Investigative …, 2002 - Elsevier
CD14 and the toll-like receptor 4 have been known to play an important role in
lipopolysaccharide-induced cellular responses in bacterial infections. Although CD14 and toll-like …

Clinical regressions and broad immune activation following combination therapy targeting human NKT cells in myeloma

J Richter, N Neparidze, L Zhang, S Nair… - Blood, The Journal …, 2013 - ashpublications.org
Natural killer T (iNKT) cells can help mediate immune surveillance against tumors in mice.
Prior studies targeting human iNKT cells were limited to therapy of advanced cancer and led …

[HTML][HTML] Early alterations in stem-like/marrow-resident T cells and innate and myeloid cells in preneoplastic gammopathy

…, M Shrestha, K Pendleton, AK Nooka, N Neparidze… - JCI insight, 2019 - ncbi.nlm.nih.gov
Preneoplastic lesions carry many of the antigenic targets found in cancer cells but often
exhibit prolonged dormancy. Understanding how the host response to premalignancy is …

[PDF][PDF] Malignancies associated with epstein-barr virus: pathobiology, clinical features, and evolving treatments

N Neparidze, J Lacy - Clin Adv Hematol Oncol, 2014 - hematologyandoncology.net
Epstein-Barr virus (EBV) is associated with a wide variety of B-cell–derived lymphoid neoplasms,
including Burkitt lymphoma, lymphomas arising in immunocompromised patients (post-…

Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States

…, JP Bewersdorf, SF Huntington, N Neparidze… - Blood …, 2020 - ashpublications.org
The hypomethylating agents (HMAs) azacitidine and decitabine have been the de facto
standard of care for patients with acute myeloid leukemia (AML) who are unfit for intensive …

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents

…, X Ma, CP Gross, AJ Davidoff, N Neparidze - Blood …, 2020 - ashpublications.org
Chromosome 1 abnormalities (C1As) are common genetic aberrations among patients with
multiple myeloma (MM). We aimed to evaluate the significance of C1As among a …

[HTML][HTML] Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer

…, M Samur, S McCachren, SN Gettinger, N Neparidze… - JCI insight, 2020 - ncbi.nlm.nih.gov
BACKGROUND PD-1 and PD-L1 have been studied interchangeably in the clinic as
checkpoints to reinvigorate T cells in diverse tumor types. Data for biologic effects of checkpoint …

A highly efficient and faithful MDS patient-derived xenotransplantation model for pre-clinical studies

…, J Zhao, N Podoltsev, M Xu, N Neparidze… - Nature …, 2019 - nature.com
Comprehensive preclinical studies of Myelodysplastic Syndromes (MDS) have been elusive
due to limited ability of MDS stem cells to engraft current immunodeficient murine hosts. …

Whole-exome sequencing in evaluation of patients with venous thromboembolism

…, C Cromwell, N Bar, S Halene, N Neparidze… - Blood …, 2017 - ashpublications.org
Genetics play a significant role in venous thromboembolism (VTE), yet current clinical
laboratory-based testing identifies a known heritable thrombophilia (factor V Leiden, prothrombin …